Ayvakit Archives -

Blueprint Medicines has taken an unusual route to raising cash for its R&D pipeline – selling off some

Blueprint cashes in on the past to build its future

https://pharmaphorum.com/news/blueprint-cashes-in-on-the-past-to-build-its-future/

Blueprint Medicines has claimed its second FDA approval for Ayvakit, getting the nod for advanced systemic mastocytosis (SM),

Blueprint’s latest approval for Ayvakit sets up clash with Novartis

https://pharmaphorum.com/news/blueprints-latest-approval-for-ayvakit-sets-up-clash-with-novartis/

The FDA has turned down Blueprint Medicines’ Ayvakit for more general use in gastrointestinal stromal tumour –

Blueprint pays the price of Ayvakit phase 3 miss as FDA rejects drug

https://pharmaphorum.com/news/blueprint-pays-the-price-of-ayvakits-phase-3-miss-as-fda-rejects-drug/

Ayvakit